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Dental pulp stem cells, or DPSC, are neural crest-derived cells with an outstanding
capacity to differentiate alongmultiple cell lineages of interest for cell therapy. In particular,
highly efficient osteo/dentinogenic differentiation of DPSC can be achieved using simple
in vitro protocols, making these cells a very attractive and promising tool for the future
treatment of dental and periodontal diseases. Among craniomaxillofacial organs, the
tooth and salivary gland are two such cases in which complete regeneration by tissue
engineering using DPSC appears to be possible, as research over the last decade has
made substantial progress in experimental models of partial or total regeneration of both
organs, by cell recombination technology. Moreover, DPSC seem to be a particularly
good choice for the regeneration of nerve tissues, including injured or transected cranial
nerves. In this context, the oral cavity appears to be an excellent testing ground for new
regenerative therapies using DPSC. However, many issues and challenges need yet to
be addressed before these cells can be employed in clinical therapy. In this review, we
point out some important aspects on the biology of DPSC with regard to their use for the
reconstruction of different craniomaxillofacial tissues and organs, with special emphasis
on cranial bones, nerves, teeth, and salivary glands.We suggest new ideas and strategies
to fully exploit the capacities of DPSC for bioengineering of the aforementioned tissues.
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INTRODUCTION: DPSC AND TISSUE ENGINEERING OF THE
ORAL CAVITY
The oral cavity is a complex multi-organic structure. Because oral tissues and organs are
functionally connected at many levels, irreversible damage to any of them is likely to eventually
affect the others, causing extensive malfunction. Tooth decay, periodontal disease, alveolar bone
resorption, orthodontic problems, orofacial neuropathic pain, and impaired salivary gland function
are conditions that seriously affect oral health of a large part of the world population. Owing to their
functional connectivity, once damage is diagnosed to one organ of the oral cavity it is important to
intervene rapidly and efficiently, to repair or replace the injured or lost tissues, to avoid severe
degradation of oral health.
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Synthetic replacement materials and prostheses (fillings,
bridges, implants, etc.) have traditionally been the treatment
of choice to treat dental decay. However, all functions of the
original biological tooth are not fully restored by this kind of
replacement therapies. Other organs of the oral cavity (e.g.,
nerves, salivary glands) are simply not amenable to mechanical
substitution approaches. Thus, tissue engineering represents a
new collection of treatment options for the complete biological
regeneration of craniomaxillofacial tissues and organs. The
development of this field requires three essential components:
(i) stem cells, (ii) biomaterial scaffolds, and (iii) stimulating
factors or inductive signals. Tissue engineering is now fully
considered as an alternative to the conventional treatments for
dental injury and disease, offering substantial advantages over
traditional dental restoration techniques (Nör, 2006; Wang et al.,
2012).
Stem cells are the cornerstone of regenerative cell therapy.
An enormous variety of multipotent stem cells have been
isolated and studied from different human tissues, such as
the bone marrow (Ding and Morrison, 2013), adipose tissue
(Kapur et al., 2015), skin (Blanpain and Fuchs, 2009), and the
umbilical cord (Yan et al., 2013; Kalaszczynska and Ferdin,
2015). Among them, mesenchymal stem cells (MSC) are the
most promising for clinical purposes (Rastegar et al., 2010;
Ménard and Tarte, 2013). In the oral cavity, adult tooth tissues
also contain different active populations of stem cells with
mesenchymal phenotype (Huang et al., 2009). Unlike other
types of MSC, dental stem cells originate from the neural crest
(Janebodin et al., 2011) and are lineage-related with peripheral
nerve glial progenitor cells (Kaukua et al., 2014), which places
them in a privileged position to mediate regeneration of both
connective and nerve tissues (Ibarretxe et al., 2012; Martens
et al., 2013). Several types of human dental stem cells have
been identified. Among them; DFPC, Dental Follicle progenitor
cells; PDLSC, Periodontal ligament stem cell; SCAP, Stem cells
from apical papilla; SHED, Stem cells from primary exfoliated
deciduous teeth; DPSC, Dental pulp stem cells, which are
without a doubt the most used for research purposes (Figure 1).
Although it still remains a considerable challenge to obtain
all the different types of neuronal and glial cells from DPSC,
their differentiation to specialized connective tissue cells has
proven to be relatively simple. Efficient protocols for obtaining
adipocytes, chondroblasts and osteo/odontoblasts are firmly
established in the literature (Gronthos et al., 2002; Huang et al.,
2009; Kawashima, 2012).
In this review, we summarize the current understanding of
DPSC and their capacity to regenerate injured orofacial tissues,
with special focus on the teeth and associated periodontal tissues,
peripheral cranial nerves, and the salivary glands. We present the
different strategies used in experimental restorative models with
potential applications in dentistry and oral medicine, together
with the different scaffold biomaterials and stimulating factor
combinations employed to elicit an optimal cellular response
required to regenerate damaged tissues. We critically comment
on some crucial aspects to be considered for bioengineering and
the regeneration of each of these tissues, based on our own
research experience.
FIGURE 1 | Multiple differentiation potential of DPSC. DPSC are isolated
from the adult dental pulp and can be in vitro expanded and differentiated to
multiple cell lineages, including all connective tissue-lineages and some neural
cell lineages.
DPSC FOR BONE REGENERATION
Regeneration of maxillary and mandibular bone is fundamental
in the field of implantology (Lee et al., 2014). Osteogenic
differentiation of DPSC is easily induced in vitro by
adding ascorbic acid (Asc), dexamethasone (Dexa), and β-
glycerophosphate (β-gly) to the culture medium, along with fetal
bovine serum (Laino et al., 2005; Langenbach and Handschel,
2013). Asc is an essential enzyme cofactor to generate pro-
collagen (Vater et al., 2011), which is necessary for the correct
synthesis of Collagen type I, the main organic component of
the bone matrix. Dexa is required for osteoblast differentiation,
working as Runx2 inductor by activating WNT/β-catenin
signaling inMSC (Hamidouche et al., 2008). Runx2 transcription
factor expression is fundamental in driving cellular commitment
to osteogenic lineages. Finally, β-gly is a donor of inorganic
phosphate, which is essential for creating hydroxyapatite
mineral, and as a signaling molecule to induce DPSC osteo-
differentiation (Foster et al., 2006; Fatherazi et al., 2009; Tada
et al., 2011).
The application of this differentiation cocktail is highly
effective in inducing DPSC to generate a mineralized bone-
like extracellular matrix in vitro. When DPSC are exposed
to this differentiation cocktail for 7–21 days, they start to
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strongly express different osteoblast differentiation markers,
such as Osterix, Runx2, osteocalcin, and bone sialoprotein.
Alkaline phosphatase (ALP), and Alizarin red staining are
positive under these conditions, and are used to demonstrate
effective differentiation of DPSC to functional osteoblasts, and
the generation of a calcified hydroxyapatite (HA)-containing
extracellular matrix (Mangano et al., 2010; Yu et al., 2010; Li
et al., 2011). DPSC-derived osteoblasts are phenotypically and
functionally similar to normal primary osteoblasts, although
some differences remain in terms of their gene expression
profiles (Carinci et al., 2008). Naïve undifferentiated DPSC
are negative for the adult osteo/odontoblast differentiation
marker Osterix, but nevertheless exhibit detectable levels of
Runx2, suggesting they are primed or pre-committed to
differentiate to osteo/odontoblasts (Yu et al., 2010). When
the osteogenic differentiation cocktail is added to DPSC,
Runx2, and Osterix expression increase and these cells generate
extracellular calcified bone-like matrix nodules, that stain
distinctively and positively with Alizarin red (Laino et al., 2005;
Figure 2).
In the last few years the use of DPSC for in vivo bone
regeneration by tissue engineering has been extensively studied
by relying on these protocols and using different experimental
models and types of scaffolds with different results (Morad
et al., 2013). Woven bone chips obtained by human DPSC
(hDPSC) osteoinduction are able to induce the generation of
adult bone tissue with an integral blood supply, when they
are heterotopically transplanted in immune-compromised
FIGURE 2 | Osteogenic differentiation of DPSC. In the presence of a
three-ingredient cocktail containing dexamethasone, β-glycerophosphate and
ascorbate added to the culture medium for 7 days, DPSC differentiate to
osteoblast-like cells that generate a mineralized bone tissue matrix that stains
positively for Alizarin red.
(IC) animals (d’Aquino et al., 2007). However, the use of
scaffolding materials is often necessary to optimize the 3D
structure of the formed bone tissue and enhance the osteoblastic
differentiation of hDPSC. To this end, different materials have
been successfully employed as a vehicle of hDPSC, including 3D
gelatin scaffolds (Li et al., 2011), self-assembling biodegradable
peptide nanofiber hydrogels (Chan et al., 2011), CaP/PLGA
(calcium phosphate/polylactic-co-glycolic acid) scaffolds
(Graziano et al., 2008a,b), particulate hydroxyapatite/tricalcium
phosphate (HA/TCP) ceramic scaffolds (Zhang et al., 2008),
and natural scaffolds like biocoral (Mangano et al., 2011) and
chitosan/collagen (Yang et al., 2011). Finally, alginate and
PuraMatrix™ hydrogels also provide a three dimensional (3D)
biodegradable carrier of stem cells for bone tissue engineering
purposes, with the additional large advantage that these
formulations are injectable, forming 3D hydrogels upon contact
with the physiological environment and thus completely filling
the tissue lesion, with minimally invasive dental and orthopedic
surgeries. Dental stem cells encapsulated in either alginate or
PuraMatrix™ exhibited high capacities for osteo-differentiation
both in vitro and in vivo (Misawa et al., 2006; Cavalcanti et al.,
2013; Moshaverinia et al., 2013).
Inductive signals also play a critical role to stimulate
development of new bone tissue. The development of a well-
defined, safe, and controlled technique to obtain and locally
deliver growth factors derived from autologous plasma has
provided a powerful tool to enhance bone tissue regeneration,
which has been successfully implemented in the clinical practice
(Anitua et al., 2008, 2012). Formulations such as Platelet-rich
plasma (PRP), Platelet-rich fibrin (PRF), and Plasma rich in
growth factors (PRGF) provide a biologically enriched culture
medium for the stimulation and functional differentiation of
primary cells with latent regenerative potential. Several studies
have shown that PRGF in particular provides additional benefits
for bone regeneration (Paknejad et al., 2012; Rivera et al., 2013).
It has been reported that PRP and PRGF induce proliferation
and enhance osteogenic differentiation in SHEDs, DPSCs, and
PDLSCs (Lee et al., 2011). Other studies have used recombinant
human Bone morphogenetic protein 2 (rhBMP-2) to enhance
osteogenic differentiation of DPSC in animal models of alveolar
bone reconstruction (Liu et al., 2011). The use of rhBMP-2 is
approved and widely extended to perform maxillary sinus floor
augmentation in dental practice (Nazirkar et al., 2014; Freitas
et al., 2015).
Despite a large body of preclinical evidence, very few clinical
trials have still been performed to evaluate new advanced
therapeutic medicinal products (ATMP) for bone regeneration
based on DPSC (La Noce et al., 2014). A notable exception is one
clinical trial performed with seven patients to repair mandibular
bone defects by transplant of DPSC in a collagen scaffold
(d’Aquino et al., 2009). After 3 years of follow-up, the clinical
outcomes were positive (Giuliani et al., 2013). However, several
obstacles remain, including a changing regulatory framework,
a shortage of technology for automation of cell production by
Goodmanufacturing practice (GMP) standards, a non-alignment
between academic and industrial research, and a need for long-
term product follow-up (La Noce et al., 2014; Leijten et al., 2015).
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These limitations have hampered the emergence of DPSC as a
tool to enhance bone regeneration at clinical level.
DPSC FOR DENTAL PULP REGENERATION
Caries and root fracture are the cause of approximately fifty
percent of all tooth extractions. Tooth injuries such as pulp
exposure, deep caries and irreversible pulpitis are currently
treated by endodontics and dental refilling/reconstruction. This
procedure usually entails the amputation or entire removal of
the dental pulp and replacement of the tissue with an inert
material. Root fracture and tooth loss are closely related to this
loss of pulp vitality because innervation and vasculature affect
pulp homeostasis and root dentin regeneration. The regeneration
of pulp injuries has become a goal for functional tooth restoration
in dentistry (Nakashima and Akamine, 2005; Nakashima et al.,
2009).
The first research reports on DPSC showed that these cells
present optimal characteristics to attain functional regeneration
of the dental-pulp chamber. Xenogenic transplant of HA/TCP
scaffolds with hDPSC into the dermis of IC mice resulted in
the formation of pulp-like tissue and polarized odontoblasts
that produced tubular dentin, showing that dentinogenic
differentiation was one of the prime or default programs
established in the DPSC phenotype (Gronthos et al., 2000,
2002). Recently, more refined studies combining SHED with
injectable scaffolds (Puramatrix™ and rhCollagen type I) have
demonstrated that dental stem cells are not only kept alive when
injected into human premolar root canals in vivo, but are also
able to fully reconstruct vascularized pulp tissue throughout the
root canal, and to differentiate to DSPP and DMP-expressing
odontoblasts that generate new dentin (Rosa et al., 2013).
In a similar experimental design, other authors employed
combinations of DPSC and umbilical vein endothelial cells
embedded in Puramatrix™ scaffold, to improve vascularization
and angiogenesis of de novo formed dental pulp-like tissue
(Dissanayaka et al., 2015).
Other studies have focused on the regenerative potential of
different cytokines and growth factors, with the goal to improve
cellular chemotaxis and cell homing into the emptied dental
pulp space in vivo. Different combinations of cytokines and
growth factors which included basic Fibroblast growth factor
(bFGF), Platelet derived growth factor (PDGF), or Vascular
endothelial growth factor (VEGF) in the presence of basal levels
of Nerve growth factor (NGF) and BMP-7 were effective in
regenerating a revascularized and recellularized dental pulp-like
tissue integrated into endodontically-treated root canal dentinal
walls in vivo (Kim et al., 2010). In addition, it has been shown
that bFGF and Stromal-derived factor (SDF1) also exert a
potent chemotactic recruitment on DPSC, while BMP-7 induces
their differentiation (Suzuki et al., 2011). In a recent study,
SDF1 loaded onto silk-fibroin scaffolds promoted the complete
regeneration and revascularization of the dental pulp of mature
dog teeth that had been subjected to endodontic treatment in
situ (Yang et al., 2015), suggesting a promising future for the
functional reconstruction of dental pulp tissue in next generation
dentistry.
DPSC FOR COMPLETE DENTAL
REGENERATION
In 2009, a ground-breaking report was published by the group
of T. Tsuji on the generation of complete and fully functional
teeth by combining isolated mouse dental epithelial and MSC
(Ikeda et al., 2009). More recently, in 2011, the same research
group developed a complete tooth unit consisting of a mature
tooth, periodontal ligament and alveolar bone, using a similar
recombination technique (Oshima et al., 2011). These tooth units
were transplanted into toothless mouse jaw regions in vivo,
and erupted correctly and in occlusion. They also presented an
adequate dental structure, an adequate hardness of enamel and
dentin, a proper function of the periodontal ligament, a positive
alveolar bone remodeling response to orthodontic forces, and a
positive response to noxious stimuli such as mechanical stress
and pain.
Although precise replication of these results has not yet been
reported on the literature, the aforementioned work represents
a substantial advance in stem cell combination technology,
with the potential to develop completely new bioengineered
replacement organs for next generation regenerative therapy.
One of the main limitations to date is probably the lack of
consistent sources of epithelial cells that can be combined
with dental mesenchymal cells (DPSC or others) to generate
a complete bioengineered tooth germ. The team of T. Tsuji
employed embryonicmouse tooth germ epithelia as precursors of
the enamel organ, a structure that fully disappears in adult teeth.
In the search for dental-competent sources of epithelial stem
cells, some authors have reported success using adult gingival
epithelial cells, which upon recombination with mesenchymal
cells generate mature teeth and form enamel and dentin
(Angelova Volponi et al., 2013). Other authors have employed
iPS-derived cells to generate mature bioengineered teeth by
similar recombination methods (Wen et al., 2012; Cai et al., 2013;
Otsu et al., 2014). The substantial progress made in the field of
dental bioengineering warrants further research on this line for
the next years.
DPSC FOR REGENERATION OF NERVE
TISSUE AND DAMAGED CRANIAL NERVES
DSPC originate from the neural crest (Janebodin et al., 2011) and
share a common origin with peripheral nerve glial progenitor
cells (Kaukua et al., 2014). These features make DPSC a very
interesting choice for regeneration of the peripheral nervous
system, including nerves of the oral cavity. Some reports claim
that DPSC can even differentiate to functionally active adult
neurons (Arthur et al., 2008; Kiraly et al., 2009; Gervois et al.,
2015). These conclusions are based on the acquisition of neuron-
specific gene and protein markers by DPSC, and also on their
capacity to generate neuronal-like voltage-dependent sodium
and calcium currents, and action potential-like membrane
voltage oscillations. However, it should be noted that to date
there has been no definite proof of differentiation of DPSC
to genuine neurons that can exhibit repetitive firing of action
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potentials upon electrical stimulation, and establish synapses
showing functional plasticity as identified by transmission
electron microscopy (TEM).
However, it is undeniable that DPSC present some striking
similarities with neural stem cells. When DPSC are grown
in culture conditions lacking fetal serum, they reorganize
morphologically and switch from a uniform cell monolayer
to a more quiescent state characterized by the appearance
of prominent spheroid structures that resemble CNS-derived
neurospheres which stain positively for the neural stem cell
marker Nestin (Ibarretxe et al., 2012; Bonnamain et al., 2013;
Xiao and Tsutsui, 2013; Gervois et al., 2015; Figure 3). Migratory
cells are occasionally observed to leave the DPSC spheroids
and virtually all these cells express the neuron-lineage marker
β3-tubulin. Moreover, their morphology is in some cases
surprisingly similar to migratory neuroblasts, with a long and
thin leading process terminated by a prominent growth cone,
and a trailing cell body displaying a few short cytoplasmic
processes (Marín et al., 2006). However, a note of caution
should be added: another cell type of the dental pulp, the
odontoblast, is also characterized by the expression of Nestin,
the generation of voltage-dependent Na+ currents, and a similar
morphology (Fujita et al., 2006; Ichikawa et al., 2012). The DPSC
population grown in these conditions is fairly heterogeneous,
both morphologically and physiologically, with a range of
different morphologies from fibroblast-like to neuroblast-like
cells, and also a variable rate of response to stimulation with
neurotransmitter receptor agonists.
Regardless of the debate on the true capacity of DPSC to
differentiate to neurons and other neural cell lineages, there is
little doubt that these cells could be a very interesting choice to
repair injured nerve tissues as a result of their active secretion
of neurotrophic and immune-modulatory factors (Nosrat et al.,
2004; Pierdomenico et al., 2005). The high expression of certain
neural markers and neurotransmitter receptors by DPSC also
suggests that these cells may actively respond to signals of
the neural environment and effectively integrate into injured
nerve tissues, promoting the reestablishment of functional nerve
connectivity (Arthur et al., 2009; Kadar et al., 2009; Kiraly et al.,
2009). For instance, some recent reports show that transplanted
DPSC are able to differentiate in vivo to myelinating cells in the
spinal cord, replacing lost cells and promoting regeneration of
transected axons in acute models of spinal cord injury (Sakai
et al., 2012).
In the case of the peripheral nerve system, treatment of nerve
injuries represents a clinical challenge because of the difficulties
of regenerating transected nerves. Though numerous surgical
successes have been reported with a short nerve gap, there is
still no satisfactory technique for long nerve defects, which often
require a complex clinical reconstruction. Autologous nerve
grafting has been considered the gold standard for repairing
peripheral nerve gaps caused by traffic accidents or tumor
resectioning (Kumar and Hassan, 2002; Hayashi and Maruyama,
2005; Bae et al., 2006). However, this technique has inevitable
disadvantages, such as a limited supply of available nerve grafts
and permanent loss of the sacrificed donor nerve function. Brain-
derived neural progenitor cells also promote regeneration of
FIGURE 3 | Neurosphere-like properties of DPSC-derived spheroids.
(Top) DPSC grown in serum-devoid conditions rearrange to form characteristic
spheroids that stain positive for neural stem cell markers. (Bottom) Migratory
cells outside of the spheroids express some neuronal markers and present a
variable morphology, with either fibroblast-like or neuroblast-like features.
transected nerves (Murakami et al., 2003). However, the use of
cells from other neural tissues involves potentially serious clinical
complications along with ethical considerations.
Taking all these arguments into account, there is an active
search for new sources of cells to be used in craniofacial nerve
bridging and regeneration. Considerable advances have been
made in this field using DPSC for the treatment of facial nerve
injuries. Particularly, patients with facial paralysis, especially
younger ones, may experience tremendous psychosocial distress
about their condition (Chan and Byrne, 2011). Recent studies
have used DPSC transplanted in PLGA tube scaffolds to achieve
a complete functional regeneration of the facial nerve in rats
to recovery levels comparable to those obtained with peripheral
nerve autografts (Sasaki et al., 2011, 2014). Interestingly, recent
research also indicates that hDPSC can be differentiated to
Schwann-like cells that efficiently myelinate DRG neuron axons
in vitro, a finding confirmed by ultrastructural TEM analysis
(Martens et al., 2014). Considering the important role that
Schwann cells play in axonal protection and regeneration of
peripheral nerves (Walsh and Midha, 2009), and the difficulty
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of their harvesting and maintenance, the generation of DPSC-
derived autologous Schwann cells may represent a milestone in
the design of new treatments for conditions of peripheral nerve
injury, including facial paralysis.
Finally, another important property of DPSC is their active
secretion of neurotrophic factors (Nosrat et al., 2004; Bray
et al., 2014), which may be exploited to treat neuropathic
pain states associated with peripheral nerve injury. In the case
of orofacial pain, some of the most distressing and painful
conditions that can be experienced by a human being are
neuralgias affecting the trigeminal nerve, or CN V. These are
characterized by intense stabbing pain and spasms, usually
associated with a mechanical injury, compression, demyelination
and inflammation of trigeminal sensory fibers (Love and
Coakham, 2001; Sabalys et al., 2013). It is known that local
application of Glial derived neurotrophic factor (GDNF) exerts a
potent analgesic effect and reverses the symptoms associated with
neuropathic pain (Boucher et al., 2000). Because DPSC secrete
important amounts of GDNF, it is conceivable that autologous
DPSC transplantation to the injured trigeminal nerve may also
potentially provide important benefits to treat severe orofacial
pain disorders, alone or in combination with pharmacological
enhancers of GDNF signaling (Hedstrom et al., 2014), some of
which are even formulated to permit topical application.
DPSC FOR SALIVARY GLAND
REGENERATION
Salivary gland regeneration is an area of intense research because
the most common treatment for head and neck cancer (i.e.,
radiotherapy) irreversibly affects salivary gland function, causing
hyposalivation and xerostomia. In consequence, difficulty in
mastication, swallowing, taste, speech, rampant dental caries
and mucosa infections appear, leading to high discomfort in
patients and a reduced quality of life (Vissink et al., 2010).
Palliative treatments such as mechanical stimulation of salivary
gland activity (chewing gum), or pharmacological agents such
as pilocarpine (Salagen™), as well as saliva substitutes, show a
limited efficacy in relieving the symptoms (Taylor, 2003).
Tissue engineering of a salivary gland replacement organ
would be a conclusive way to treat these patients. To accomplish
this complex task, there are some issues that must be taken into
account: (i) optimization of the 3D scaffold material properties
(including non-toxicity, permeability and biodegradability,
among others), (ii) identification of an epithelial stem cell
population capable of appropriate salivary differentiation (iii)
definition of ideal culture conditions and extracellular matrix
components (ECM) with laminin, integrins, MMPs to mimic
the microenvironment of the gland, and (iv) selection of a
population of MSC to be combined with salivary epithelial
cells to generate a full bioengineered salivary gland germ.
Finally, in comparison with dental bioengineering, salivary gland
bioengineering presents an important additional requirement:
apart from the communication between the epithelium and
the mesenchyme, epithelial-axonal interactions are also required
from the very beginning of salivary gland morphogenesis,
because innervation plays an important role in regulating the
activity of epithelial progenitor cells (Knox et al., 2010) and
salivary gland branching and tubulogenesis (Nedvetsky et al.,
2014). Therefore, salivary gland bioengineering strategies must
also take into account that this is an organ that heavily relies
on the establishment of a functional innervation to properly
complete its development (Lombaert et al., 2011; Knosp et al.,
2012).
Some studies indicate that isolated mouse salivary gland
stem cells (cKit+, CK14+, Msi-1+, and Sca-1+) can grow
and form salispheres that produce amylase (Lombaert et al.,
2008). Moreover, injection of a liquid suspension containing
only 300–400 cKit+ cells into the mouse SMG was shown to
partially rescue the loss of morphology and function induced by
irradiation insults (Lombaert et al., 2008; Coppes and Stokman,
2011; Nanduri et al., 2013). In recent years, the technology
to generate salivary gland organoids in vitro has progressed
remarkably. Recentmajor advances in the field include the advent
of bioengineered glands constructed from dissociated cells from
adult and fetal salivary glands (Ogawa et al., 2013; Nanduri
et al., 2014). An important study by the group of T. Tsuji
showed that the bioengineered salivary glands generated by a
cell recombination protocol contained epithelium, mesenchyme,
endothelium, and nerve cells. Most importantly, the entire organ
could be transplanted into adult mice, reconnect with the existing
ductal system and function properly (Ogawa et al., 2013; Ogawa
and Tsuji, 2015). Thus, the salivary gland joins the tooth in the list
of organs that can be fully generated ex vivo by tissue engineering.
As in the case of the tooth, the main challenge to translate these
findings to clinical practice is still the need for sources of stem
cells that are sufficiently abundant and competent for salivary
epithelial differentiation, and that do not involve destruction of
donor salivary gland tissue.
In the search for stem cell sources to be employed in salivary
gland bioengineering, some progress has been recently made
using DPSC. It has been shown that DPSC contribute to the
generation of salisphere-like structures when combined with
Human salivary gland (HSG) cell lines in either Matrigel™ or
hyaluronic acid hydrogel scaffolds (Janebodin and Reyes, 2012).
These salispheres expressed markers of terminally differentiated
acinar cells, and generated a well-irrigated salivary gland-
like tissue after subcutaneous transplantation in IC mice.
The principal role of DPSC in salivary gland bioengineering
is to generate the salivary stroma or mesenchymal-derived
compartment, and these cells are in theory one of the best
choices for that purpose because the tooth mesenchyme and the
salivary gland mesenchyme share a common embryonic origin
(i.e., neural crest).
HSG are stable cell lines derived from neoplastic tissues
(Shirasuna et al., 1981) and definitely not the best choice
to bioengineer a physiologically functional salivary gland. In
order to evaluate whether trophic support provided by DPSC
sustains proliferation and ramification of primary salivary
gland epithelia in developmental stages, in vitro recombination
experiments between isolated embryonicmouse salivary epithelia
and dissociated hDPSC may be performed in 3D laminin or
other extracellular matrix scaffolds (Sequeira et al., 2013). In
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FIGURE 4 | Recombination of salivary gland germ epithelia with DPSC
in 3D culture. (A) SMG epithelia can be mechanically and enzymatically
isolated from SMG mesenchyme, and recombined with hDPSC in 3D laminin
scaffolds to generate a bioengineered salivary gland germ (B) SMG acini from
E14.5 mouse, showing the extensive natural innervation of the SMG by
β3-tubulin+ nerve fibers at this developmental stage. (C) SMG acini from
E14.5 mouse, showing the natural localization of Laminin in the basal lamina
that separates the salivary epithelium and mesenchyme.
these conditions, DPSC bind and interact with isolated salivary
epithelia, improving the in vitro viability of the tissue (Figure 4).
However, recombination with DPSC alone is clearly insufficient
to promote long-term growth and ramification of developing
salivary epithelia. One missing but important potential factor
is that this system cannot reproduce the extensive innervation
that occurs within normal salivary gland tissues and plays a
crucial role in salivary gland growth and morphogenesis (Knox
et al., 2010; Knosp et al., 2012). Next steps in this direction
should involve the addition of specific growth factors that sustain
epithelial cell growth and commitment to salivary gland cell
differentiation, as well as the use of coculture systems between
bioengineered salivary glands and nerve cells to attempt tomimic
the growth stimulatory effect of natural salivary innervation.
CONCLUDING REMARKS
DPSC have emerged as a very promising tool with a great
potential to be used in tissue engineering models aimed at
the functional reconstruction of different craniomaxillofacial
organs. Some of the main advantages of these cells are their
multifaceted differentiation capacity, along with their non-
tumorigenic phenotype, a high proliferation rate, a relative
simplicity of extraction and culture, and their possibility of
cryopreservation, which ultimately make possible to obtain
patient-specific cell lines for their use in autologous cell therapy.
However, many issues and challenges still need to be addressed
before these cells can be employed in clinical practice. The
full control of differentiation of DPSC to specific fates is
still one important issue, and although DPSC derivation to
certain connective tissue-lineage cells appears to be relatively
simple, their differentiation into nerve-tissue lineages still poses
important unanswered questions. Moreover, the development
of the cell recombination technology required to create next
generation bioengineered replacement organs will necessitate
extensive research for the coming years. In this case, DPSC
may be an ideal choice to be used in experimental models of
tissue-engineered reconstruction of organs of the oral cavity, and
the paradigmatic cases of the tooth and the salivary gland may
constitute the leading edge of a massive research effort on next
generation organ replacement therapies.
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